Interface between authorship, industry and science in the domain of therapeutics
Open Access
- 1 July 2003
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 183 (1), 22-27
- https://doi.org/10.1192/bjp.183.1.22
Abstract
Background Changes in the character of medical authorship.Keywords
This publication has 12 references indexed in Scilit:
- SSRIs and deliberate self-harmThe British Journal of Psychiatry, 2002
- Sponsorship, Authorship, and AccountabilityThe New England Journal of Medicine, 2001
- Sponsorship, Authorship, and AccountabilityThe New England Journal of Medicine, 2001
- Adverse events reporting—the tip of an icebergAccountability in Research, 2001
- Predictive value of pharmacological activity for the relative efficacy of antidepressant drugsThe British Journal of Psychiatry, 2000
- The Contributions of AuthorsJAMA, 2000
- Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical TrialsArchives of General Psychiatry, 2000
- Publication bias and the integrity of psychiatry researchPsychological Medicine, 2000
- Sertraline Treatment of Children and Adolescents With Obsessive‐Compulsive Disorder or Depression: Pharmacokinetics, Tolerability, and EfficacyJournal of the American Academy of Child & Adolescent Psychiatry, 1998
- SSRI-Induced extrapyramidal side-effects and akathisia: implications for treatmentJournal of Psychopharmacology, 1998